HIVPediatrics
Topics
Meeting category
Date(s)
11 Jul 2025 - 12 Jul 2025
Important dates
Early Registration Fee Deadline
Wednesday, 11 December at 23:59 CAT
Location
Kigali, Rwanda

International Workshop on Pediatrics & HIV 2025

General
What's New

Welcome

The 17th International Workshop on Pediatrics & HIV will take place in a hybrid format from 11-12 July 2025 in Kigali, Rwanda.

Although we have witnessed a dramatic global scale-up of antiretroviral treatment (ART) as well as efforts to prevent vertical HIV transmission in the last decade, there were 150,000 new pediatric infections in 2021 and an estimated 1.68 million children <15 years of age living with HIV. Children are substantially less likely than adults to be diagnosed, initiate treatment, and achieve durable viral suppression. Currently, only 54% are receiving ART, and treatment of pediatric HIV, particularly in infants and young children, remains complex and problematic, with continued use of suboptimal ART formulations and regimens. 

Furthermore, adolescents are one of the most rapidly growing populations with HIV; in 2021, there were an estimated 410,000 new HIV infections among young people aged 15- 24 years, accounting for 27% of all new HIV infections globally. HIV infections among adolescent girls and young women are 65% higher than among adolescent boys and young men of the same age, with 4,900 new infections occurring in young women weekly. HIV remains one of the leading causes of death among adolescents living in Africa and among the top 10 causes of death in adolescents globally. The uptake of HIV testing among adolescents has remained low. Programs continue to struggle to reach and retain adolescents in care, and adherence to treatment has special challenges, particularly among those with perinatal infection aging up into adolescence and young adulthood. 

As research to improve pediatric HIV diagnosis and care is ongoing, new scientific questions of critical importance have also emerged. In settings with mature ART programs, an increasing proportion of new pediatric infections is attributed to women acquiring HIV infection during pregnancy and breastfeeding, periods of markedly increased risk of HIV acquisition for the mother. With the scale-up of ART for PMTCT, the prevalence of pre-treatment antiretroviral (ARV) drug resistance, particularly to non-nucleoside reverse transcriptase inhibitor drugs, has escalated among newly diagnosed infants, jeopardizing ART effectiveness. Additionally, with more than 1.3 million pregnant women globally receiving ART, there are increasing concerns about the long-term impact of in utero and postnatal exposures to medications for those children who escape HIV. 

Currently, the global population of HIV-exposed uninfected children and adolescents is estimated at 14.8 million, including over 8 million with in-utero ARV exposure. An initial early report of an association with periconception dolutegravir exposure and increased risk of neural tube defects, which upon an increase in the number of periconception exposures subsequently is no longer found, has underscored the need for ongoing attention to surveillance of safety of ARVs in pregnancy. Innovation in early infant diagnosis such as point-of-care tests has facilitated earlier identification of HIV infection during infancy, providing exciting new opportunities to study acute infection and very early treatment in neonates and promising remission strategies. However, despite the critical importance of these topics, research in pediatric, adolescent, and maternal HIV infection is often neglected at major scientific HIV conferences. 

Therefore, in collaboration with leading experts in the field, we have established a highly focused international workshop on the prevention and treatment of pediatric HIV. The overall objective of the International Workshop on Pediatrics & HIV is to stimulate research that will advance prevention and treatment strategies for infants, children, and adolescents. 

Workshop Chairs
General Information 
Who Should Attend?
- Researchers

- Clinicians

- Nurses

- Industry specialists working in academic settings, hospitals, and non-governmental organizations (NGO)
Meeting Objectives
The meeting aims at:

- Enhancing communication and encouraging collaboration between junior and senior investigators, north and south, and academia, governmental public health agencies, and industry to promote advances in HIV prevention and care in children, adolescents and families.

- Disseminating knowledge and data exchanged by workshop participants beyond the audience of the live event through posting of all presentations on the meeting website, thus maximizing the impact of the meeting by reaching the whole HIV research community.

- Providing updates on the latest research on new pediatric antiretroviral drugs and treatment and prevention strategies in children and adolescents.

- Understanding how to optimize recognition and treatment of advanced HIV disease in children and adolescents.

- Providing updates on new strategies for HIV prevention in children, adolescents and pregnant women, including long-acting antiretroviral agents and HIV vaccines.

- Evaluating effectiveness of and gaps in programs for the prevention of perinatal HIV transmission and interventions to improve such programs.

- Sharing results of implementation science research on how to optimally implement programs for prevention or treatment of HIV in infants, children, adolescents and pregnant women in developing countries.

- Understanding the complications of long-term HIV infection and its therapy, to enable improved management of HIV in children and adolescents.

- Providing update on prevention or treatment of coinfections, such as tuberculosis and hepatitis C, in children and adolescents.
Practical Information 
Badges
All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Enduring Materials
Enduring materials will be available here 3 weeks after the conclusion of the workshop.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here 3 weeks after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Registration is now open.
Register
Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.
Fees and Conditions

Regular Delegates-
In-Person 

Regular Delegates-
Virtual 

 Industry* - In-Person  Industry* - Virtual 

Early Fee (payment before/on 11 December 2025)

€595

€495

 €795 €695

Standard Fee (payment before/on 11 May 2025)

€745

€595

 €995 €895

Late Fee (Payment from 12 May 2025)

€795

€695

 €1,095.00 €995

Fee Waivers

Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract

50% Off Early Fee

Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITHOUT accepted abstract

50% Off Current Regular Fee

NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates

50% Off Current Regular Fee

Members of Endorsers  

25% Off Current Regular Fee

 Sponsors 

Contact Secretariat 

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important

  • We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
For onsite attendees:

- Access to all scientific sessions, including poster area

- Workshop pack, including abstract book and program

- Refreshments during the coffee breaks

- Buffet lunch on workshop days

For virtual attendees only:

- Access to all scientific sessions

- Digital workshop pack, including the program

IMPORTANT:

- No day rate is available

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact Christina Moustakaki at Christina.Moustakaki@amededu.com to use the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to 50% discount on the Early Fee for regular delegates from low-income and lower-middle-income countries and early-career investigators with an accepted abstract. Additionally, a 50% discount on the regular fee will be provided for those without an accepted abstract. The application form is available below.

IMPORTANT: The discount is offered to the presenting author only.

To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 11 June 2025: 50% refund (minus an administration fee of €40)

- Cancellation after 11 June 2025: Unfortunately, no refund will be given

If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 27 June 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for HIV & Pediatrics 2024, the workshop secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the AIDS 2024 embargo policy: https://www.iasociety.org/conferences/aids2024/media/conference-embargo-policy
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
Preliminary Program

The program of Pediatrics & HIV 2025 is currently under development.

To view the 2024 program, please click here.

Committees
Workshop Chairs 2025
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee

We are proud to present the members of the committee:

  • Adam Bartlett, BSc, MBBS, MPHTM, PhD, FRACP - Sydney Children's Hospital / Kirby Institute, Australia

  • Jason Brophy, MD, MSc, DTM, FRCPC - Children's Hospital of Eastern Ontario, Canada

  • Ellen Chadwick, MD - Ann & Robert H. Lurie Children’s Hospital of Chicago / Northwestern University Feinberg School of Medicine, United States

  • Tsungai Chipato, MBChB - University of Zimbabwe College of Health Sciences, Zimbabwe

  • Polly Clayden - HIV i-Base, United Kingdom

  • Anita De Rossi, PhD - University of Padova / Istituto Oncologico Veneto (IOV)-IRCCS, Italy

  • Marinella Della Negra, MD, PhD - Hospital Emilio Ribas, Brazil

  • Brian Eley, MD - University of Cape Town, South Africa

  • Albert Faye, PhD - Denis Diderot University, Paris, France

  • Rashida Ferrand, MBBS, FRCP, PhD - London School of Hygiene and Tropical Medicine / Biomedical Research and Training Institute, Zimbabwe

  • Patricia Flynn, MD - St. Jude Children's Research Hospital, United States

  • Tessa Goetghebuer, MD - Office de la Naissance et de l'Enfance / CHU Saint-Pierree, Belgium

  • Ali Judd, PhD, University College London, United Kingdom

  • Valériane Leroy, MD - Inserm, Paris, France

  • Chewe Luo, MD, PhD - UNICEF, United States

  • Dorothy Mbori-Ngacha, MBChB, MMed, MPH - Independent Consultant, Kenya

  • Immaculate Mutisya, MMed - Centres for Disease Control and Prevention, Kenya

  • Sharon Nachman, MD - SUNY Stony Brook / IMPAACT, United States

  • Clare Nourse, AM, BA, MB, BCH, BAO DCH, MRCPI, FRACP, MD - Children's Health Queensland / University of Queensland, Australia

  • Paul Palumbo, MD - Dartmouth-Hitchcock Medical Center, United States

  • Martina Penazzato, MD, MSc, PhD - World Health Organization, Switzerland

  • Kathleen Powis, MD, Massachusetts General Hospital, United States

  • Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS - Elizabeth Glaser Pediatrics AIDS Foundation / Children’s National Hospital, United States

  • Theodore Ruel, MD - UCSF Benioff Children's Hospital San Francisco, United States

  • George Siberry, MD, MPH, FAAP, FPIDS - United States Agency for International Development (USAID), United States

  • Lynda Stranix-Chibanda, MBChB, MMed - University of Zimbabwe, Zimbabwe

  • Tavitiya Sudjaritruk, MD, ScM, PhD - Chiang Mai University, Thailand

  • Graham Taylor, MD - Imperial College, United Kingdom

  • Claire Thorne, BA, MSc, PhD - University College London, United Kingdom

  • Priscilla Tsondai, MBChB and MPH, International AIDS Society, South Africa

  • Marissa Vicari - UNAIDS, Switzerland

  • Rachel Vreeman, MD, MS - Icahn School of Medicine at Mount Sinai, United States

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Endorsers
Endorsers

Pediatrics & HIV 2025 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop!

If you would like your organization to endorse the International Workshop on Pediatrics & HIV 2025, please contact Christina Moustakaki at Christina.Moustakaki@amededu.com.

Support

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in Pediatrics & HIV.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Karin Siebelt at Karin.Siebelt@amededu.com. 
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Previous Editions
Previous Editions
Language
Related Programs
Afbeelding
Christina M
Caption
Hi! I’m Christina
Label / Name
How can I help you?
Go to Contact form webform